GLPBio

Immunology/Inflammation

Read More about this category

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

Research Areas

Products Related to Immunology/Inflammation(4623)

  • GC80408 structure
    GC80408Meloxicam- 13 C 6
    Purity: >98.00%

    Meloxicam -13C6 is 13 C 6 -labeled Meloxicam.

  • GC80409 structure
    GC80409Deltoin
    CAS: 19662-71-6
    Purity: >98%

    Deltoin is a Coumarine derivative.

  • GC80410 structure
    GC804104'-Acetoxy resveratrol
    CAS: 411233-11-9
    Purity: >99.50%

    4'-Acetoxy resveratrol is a Resveratrol derivative.

  • GC80411 structure
    GC80411Leonuriside A
    CAS: 121748-12-7
    Purity: >99.50%

    Leonuriside A is a phenolic compound that can be isolated from Leonurus japonicus.

  • GC80412 structure
    GC80412(E)-Sinapoyl glucose
    CAS: 78185-48-5
    Purity: >99.50%

    (E)-Sinapoyl glucose is an inflammatory pathway inhibitor.

  • GC80415 structure
    GC80415(S)-Flurbiprofen-d 3
    Purity: >98%

    (S)-Flurbiprofen-d3 (Esflurbiprofen-d3) is the deuterium labeled (S)-Flurbiprofen.

  • GC80416 structure
    GC80416Omaveloxolone-d 3
    Purity: >98%

    Omaveloxolone -d 3 (RTA 408-d 3 ) is the deuterated-labeled Omaveloxolone.

  • GC80469 structure
    GC80469ω-Hexatoxin-Hv1a TFA
    Purity: >97.00%

    ω-Hexatoxin-Hv1a (ω-ACTX-Hv1; ω-Atracotoxin-HV1) TFA is an orally active insecticidal neurotoxin containing an inhibitor cystine knot motif and a selective calcium channel inhibitor.

  • GC80476 structure
    GC804763-Hydroxykynurenine- 13 C 2 , 15 N hydrochloride
    Purity: >98.50%

    3-Hydroxykynurenine - 13 C 2, 15 N (3-Hydroxy-DL-kynurenine- 13 C 2, 15 N) hydrochloride is the 13 C and 15 N labeled 3-Hydroxykynurenine hydrochloride [1] . 3-Hydroxykynurenine, a metabolite of tryptophan, is a potential endogenous neurotoxin whose increased levels have been described in several neurodegenerative disorders.

  • GC80477 structure
    GC80477Sodium butyrate-d 3
    CAS: 347840-05-5
    Purity: >99.50%

    Sodium butyrate -d 3 (Butanoic acid-d 3 sodium) is the deuterium labeled Sodium butyrate.

  • GC80509 structure
    GC80509Nervonic acid-d 18
    Purity: >98%

    Nervonic acid -d 18 (Selacholeic acid-d 18 ) is the deuterium labeled Nervonic acid.

  • GC80846 structure
    GC80846Myristic acid- 13 C 2
    CAS: 287111-20-0
    Purity: >98%

    Myristic acid - 13 C 2 is the 13 C-labeled Myristic acid.

  • GC80853 structure
    GC80853(4R,5S)-YX-02-030
    CAS: 3049077-01-9
    Purity: >99.50%

    (4R,5S)-YX-02-030 is an isomer of YX-02-030.

  • GC80863 structure
    GC80863(R)-Balcinrenone
    CAS: 1850385-65-7
    Purity: >99.50%

    (R)-Balcinrenone ((R)-AZD9977) is an isomer of Balcinrenone.

  • GC80868 structure
    GC80868Antcin K
    CAS: 741268-13-3
    Purity: >98%

    Antcin K is a selective inhibitor targeting the PI3K/Akt, NF-κB, MEK1/2-ERK, p38 and AP-1 pathways.

  • GC80869 structure
    GC80869Calebin A
    CAS: 336784-82-8
    Purity: >98.00%

    Calebin A is a PI3K/Akt/mTOR, MAPK, and NF-κB inhibitor with oral effectiveness.

  • GC80873 structure
    GC80873Tovophyllin A
    CAS: 40738-44-1
    Purity: >98%

    Tovophyllin A is an orally active xanthonoid compound.

  • GC80876 structure
    GC80876G9D-4 TFA
    Purity: >99.00%

    G9D-4 TFA is a G9a PROTAC degrader.

  • GC80877 structure
    GC80877LD-110 triTFA
    Purity: >99.50%

    LD-110 triTFA is a highly efficient and effective LSD1 PROTAC degrader ( DC 50 = 0.44 μM).

  • GC80879 structure
    GC80879JWZ-8-103 hydrochloride
    Purity: >99.50%

    JWZ-8-103 hydrochloride is an orally active analog of PRLX-93936 and a molecular glue targeting TRIM21.

  • GC80880 structure
    GC80880dCASP1-55
    Purity: >98%

    dCASP1-55 is a cereblon-dependent caspase-1 ( CASP1 ) PROTAC degrader.

  • GC80881 structure
    GC80881PROTAC DAPK1 Degrader-1
    CAS: 3063030-38-3
    Purity: >96.50%

    PROTAC DAPK1 Degrader-1 is a death-associated protein kinase 1 (DAPK1) degrader with a DC 50 of 119.6 nM.

  • GC80882 structure
    GC80882ZLY025
    CAS: 3070379-34-6
    Purity: >99.00%

    ZLY025 is a potent and orally active CCNK molecular glue degrader with an DC 50 of 42.7 nM.

  • GC80883 structure
    GC80883Thalidomide-O-amide-C5-NH2 hydrochloride
    CAS: 2716130-28-6
    Purity: >95.50%

    Thalidomide-O-amide-C5-NH2 hydrochloride is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology [1] [2] .